Solventum Corp 2026年季度报告

WASHINGTON, D.C. 20549 FORM 10-Q ☒QUARTERLY REPORT PURSUANT TO SECTION13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended March31, 2026orTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the transition period from __________ to __________ Commission file number: 001-41968 SOLVENTUM CORPORATION (Exact name of registrant as specified in its charter) (Registrant’s Telephone Number, Including Area Code)(651) 733-1110 Not Applicable (Former Name or Former Address, if Changed Since Last Report) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which registered Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Actof 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject tosuch filing requirements for the past 90 days. Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submitsuch files). Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reportingcompany, or an emerging growth company. See the definitions of"large accelerated filer,""accelerated filer,""smaller reporting company,"and"emerging growth company"in Rule 12b-2 of the Exchange Act: If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying withany new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes☐No☒ Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. SOLVENTUM CORPORATIONForm 10-Q for the period ended March31, 2026 TABLE OF CONTENTSPART I. Financial InformationItem 1. Financial StatementsCondensed Consolidated Statements of Income (Unaudited)Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)Condensed Consolidated Balance Sheets (Unaudited)Condensed Consolidated Statements of Changes in Equity (Unaudited)Condensed Consolidated Statements of Cash Flows (Unaudited)Notes to the Condensed Consolidated Financial Statements (Unaudited)NOTE 1. Significant Accounting PoliciesNOTE 2. Revenue RecognitionNOTE 3. Acquisitions and DivestituresNOTE 4. Goodwill and Intangible AssetsNOTE 5. Supplemental Financial InformationNOTE 6. Property, Plant, and Equipment - NetNOTE 7. Supplemental Equity and Comprehensive Income InformationNOTE 8. Income TaxesNOTE 9. Long-Term Debt and Short-Term BorrowingsNOTE 10. Pension and Postretirement Benefit PlansNOTE 11. DerivativesNOTE 12. Commitments and ContingenciesNOTE 13. RestructuringNOTE 14. Earnings Per ShareNOTE 15. Stock-Based CompensationNOTE 16. Related PartiesNOTE 17. Business SegmentsItem 2. Management’s Discussion and Analysis of Financial Condition and Results of OperationsOverviewResults of OperationsPerformance by Business SegmentFinancial Condition and LiquidityCautionary Note Concerning Forward Looking StatementsItem 3. Quantitative and Qualitative Disclosures About Market RiskItem 4. Controls and ProceduresPART II. Other InformationItem 1. Legal ProceedingsItem 1A. Risk FactorsItem 2. Unregistered Sales of Equity Securities and Use of ProceedsItem 3. Defaults Upon Senior SecuritiesItem 4. Mine Safety DisclosuresItem 5. Other InformationItem 6. Exhibits SOLVENTUM CORPORATIONFORM 10-QFor the Quarterly Period Ended March31, 2026PART I. Financial Information Solventum CorporationCondensed Consolidated Statements of Income (Unaudited) Solventum CorporationNotes to the Condensed Consolidated Financial Statements (Unaudited) NOTE 1. Significant Accounting Policies Organization and Description of Business Solventum Corporation ("Solventum," "we," "our," "us," or the "Company") was a business of 3M Company ("3M"). On April 1, 2024(the "Distribution Date"), 3M completed the previously announced spin-off of Solventum Corporation (the "Spin-Off"). The Spin-Offwas completed through a distribution of approximately 80.1% of the Company’s outstanding common stock to holders of record of3M’s common stock as of the close of business on March 18, 2024 (the "Distribution"), which resulted in the issuance of 172,709,505shares of common stock. As a result of the Distribution, the Company became an independent public company. Solventum’s commonstock is listed under the symbol "SOLV" on the New York Stock Exchange ("NYSE"). Solventum is a leading global heal